MedPath
HSA Approval

Atracurium-hameln Injection 10mg/ml

SIN14533P

Atracurium-hameln Injection 10mg/ml

Atracurium-hameln Injection 10mg/ml

April 1, 2014

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS

Medical Information

M03AC04

atracurium

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

Siegfried Hameln GmbH

Active Ingredients

Atracurium besilate

10.0 mg per ml

Atracurium besylate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Atracurium-hameln Injection 10mg/ml - HSA Approval | MedPath